Families with Wilsons disease in subsequent generations: clinical and genetic analysis
They are not for human or veterinary use, diagnostic use, therapeutic use, food, drug, supplement, cosmetic use, or use outside lawful laboratory research settings
The primary antibodies used were anti- VEGF-A (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- VEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- pVEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- AKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- pAKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- ERK (Cell Signaling Technology, Berkeley, CA, USA), anti- pERK (Cell SignalingT echnology, Berkeley, CA, USA), anti- p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- p-p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- eNOS (Proteintech, Chicago, IL, USA), anti- p-eNOS (Proteintech, Chicago, IL, USA), anti- CHOP (Cell Signaling Technology, Berkeley, CA, USA) and anti- -actin (Cell Signaling Technology, Berkeley, CA, USA)

Read the full breakdown: #Peptides #BPC157 #TB500 #FDA #HealthcareLaw #MedSpa #LengeaLaw #CompoundingPharmacy #MedicalCompliance To view or add a comment, sign in Most peptide discourse is two people with strong opinions and no citations